Tele: 561.316.3330
Breaking Medical Device News

Monday, October 18, 2021
HomeNovaradHospitals Partner to Implement First of Its Kind Augmented Reality Surgical Technology

Hospitals Partner to Implement First of Its Kind Augmented Reality Surgical Technology

GWU Hospital becomes first facility in the US to use AR technology to assist a surgical operation, improving accuracy and shortening operating and recovery times for patients

George Washington University Hospital, in partnership with Novarad, today announced the country’s first implementation of an augmented reality (AR) medical solution in a surgical setting. Building upon decades of Novarad’s experience in image processing, the OpenSight® Augmented Reality System, powered by Microsoft HoloLens, renders 2D, 3D and 4D images of patients interactively, while accurately overlaying them directly onto the patient’s body. The partnership ushers in a new world of pre-operative planning, overcoming critical pre-surgical and surgical obstacles to minimize patient morbidity and mortality.

While some earlier technology was limited in both scope and efficacy, OpenSight, co-created by Dr. Wendell Gibby, Novarad CEO and Dr. Steve Cvetko of OpenSight, was designed to visualize 3D imaging holograms of the patient, on the patient, for pre-operative localization and planning of surgical options. The 3D holograms are created by a refractory system in the device using a combination of the Microsoft HoloLens hardware and OpenSight technology.

“OpenSight allows the surgeon to overlay the medical image onto the patient’s body, so not only do I see the patient laying on top of the table, but I can see the CT hologram,” said Dr. Babak Sarani, professor of surgery and emergency medicine and director of the center for trauma and critical care at George Washington University, “Us having this technology meets the endpoint of our mission as an academic hospital.”

The infrared camera within the headset has ranging and localizing technology, which maps the surrounding environment – including the patient. It determines where objects are and creates mesh surface maps to determine 3D positioning. Placing visual tracking tags on the patient follows movement and allows for even higher accuracy. Image capabilities include virtual incisions to guide the surgeon, shunts, and needle placement; finding the optimal entrance and trajectory for pedicle screws, ACL tunnels and other instrumentation; finding and resecting masses; interventional biopsies, and more.

“A revolution in surgery is beginning and George Washington University is leading the charge,” said Dr. Gibby. “Using the OpenSight augmented reality device from Novarad, doctors can literally see the patient and see into them at the same time. High resolution advanced holographic imaging is merged in 3D onto the patient with optical precision. This transformative technology promises to improve outcomes in a world of more precise medicine.”

The technology available through this partnership will make it possible to highlight relevant anatomical and critical structures to avoid and more accurately plan a surgical approach. Multiple headsets can be shared among users improving the training of less experienced residents. A teaching version of the software is also available that allows medical students to perform virtual dissections on cadavers.

“Novarad’s unique OpenSight system uses the Microsoft HoloLens headset and augments real-world health care environments with virtual 3D patient images, and we are very pleased that they have achieved FDA medical clearance for pre-surgical use of their OpenSight solutions for HoloLens,” said Matt Fleckenstein, Senior Director of Marketing for Microsoft HoloLens at Microsoft Corp. “It’s exciting to see George Washington University Hospital become the first medical team to adopt this new system – empowering its doctors with the technology to improve surgical outcomes.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy